TY  - JOUR

T1  - Laboratory Parameters in Adolescent Patients Aged 12–17 with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52: Results from the Phase 3 ECZTRA 6 Trial

JO  - SKIN The Journal of Cutaneous Medicine

UR  - http://dx.doi.org/10.25251/skin.8.supp.323

PY  - 2024/01/16

AU  - Paller A

AU  - Cork M

AU  - Hong C-H

AU  - Soong W

AU  - Schneider S

AU  - Lo H

AU  - Pedersen LRM

AU  - Vacko E

AU  - Wollenberg A

ED  - 

DO  - DOI: 10.25251/skin.8.supp.323

PB  - National Society for Cutaneous Medicine

VL  - 8

IS  - 1

SP  - s323

EP  - s323

Y2  - 2024/12/22

ER  -